{
    "nct_id": "NCT06728579",
    "official_title": "Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors",
    "inclusion_criteria": "* Age â‰¥18 years\n* English-proficient women with a history of stage I, II, or III breast cancer\n* Free of oncologic disease by clinical examination and history;\n* Receiving third-generation AI therapy (anastrozole, letrozole, or exemestane) for at least 28 days prior to consent with plan to continue for at least another 12 months;\n* Worst joint pain rated at least 4 or greater on a 0-10 numeric rating scale in the preceding week prior to consent;\n* Reporting at least 15 days with pain in the preceding 30 days prior to consent;\n* Experiencing joint pain for at least one month;\n* Pain attributed to AI therapy;\n* Willing to adhere to all study-related procedures, including randomization to one of two treatment arms: Mindfulness-Oriented Recovery Enhancement (MORE) or Supportive Group Psychotherapy (SG);\n* Able to attend video-call sessions in a quiet/private location.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Metastatic breast cancer (stage IV);\n* Completed chemotherapy, surgery, or radiation therapy less than 4 weeks prior to enrollment;\n* Pain attributed to inflammatory arthritis (i.e. rheumatoid arthritis, gout, pseudogout);\n* Surgery or joint injection involving the affected joints within the last month or planned within the next six months;\n* Active suicidality or psychosis as determined by the Mini-International Neuropsychiatric Interview.",
    "miscellaneous_criteria": ""
}